Gene · 4739
Papers2,045
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,045
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-5195-3p functions as a tumor suppressor in prostate cancer via targeting CCNL1. | Cell Mol Biol Lett | 2022 | 35260070 | PubTator, text mining | PubMed |
| Expression signature of the Leigh syndrome French-Canadian type. | Mol Genet Metab Rep | 2022 | 35242578 | PubTator, text mining | PubMed |
| Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy. | Mol Cancer | 2022 | 35241090 | PubTator, text mining | PubMed |
| Pharmacological Perturbation of Mechanical Contractility Enables Robust Transdifferentiation of Human Fibroblasts into Neurons. | Adv Sci (Weinh) | 2022 | 35240008 | PubTator, text mining | PubMed |
| Unraveling the Host-Selective Toxic Interaction of Cassiicolin with Lipid Membranes and Its Cytotoxicity. | Phytopathology | 2022 | 35238604 | PubTator, text mining | PubMed |
| Proxyeconomics, a theory and model of proxy-based competition and cultural evolution. | R Soc Open Sci | 2022 | 35223051 | PubTator, text mining | PubMed |
| Depression, COVID-19 Anxiety, Subjective Well-being, and Academic Performance in University Students With COVID-19-Infected Relatives: A Network Analysis. | Front Psychol | 2022 | 35222215 | PubTator, text mining | PubMed |
| MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets. | Int J Mol Sci | 2022 | 35216281 | PubTator, text mining | PubMed |
| Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer. | Cancers (Basel) | 2022 | 35205713 | PubTator, text mining | PubMed |
| How to Find the Right RNA-Sensing CRISPR-Cas System for an In Vitro Application. | Biosensors (Basel) | 2022 | 35200314 | PubTator, text mining | PubMed |
| Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases. | J Nanostructure Chem | 2022 | 35194511 | PubTator, text mining | PubMed |
| Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis. | PeerJ | 2022 | 35178291 | PubTator, text mining | PubMed |
| Distribution, Diversity and Roles of CRISPR-Cas Systems in Human and Animal Pathogenic Streptococci. | Front Microbiol | 2022 | 35173702 | PubTator, text mining | PubMed |
| Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronaviruses. | Nucleic Acids Res | 2022 | 35166837 | PubTator, text mining | PubMed |
| Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer. | Cureus | 2022 | 35165542 | PubTator, text mining | PubMed |
| CRISPR Approaches for the Diagnosis of Human Diseases. | Int J Mol Sci | 2022 | 35163678 | PubTator, text mining | PubMed |
| Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We? | Cancers (Basel) | 2022 | 35159110 | PubTator, text mining | PubMed |
| Decoding Single Cell Morphology in Osteotropic Breast Cancer Cells for Dissecting Their Migratory, Molecular and Biophysical Heterogeneity. | Cancers (Basel) | 2022 | 35158871 | PubTator, text mining | PubMed |
| AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis. | Cancers (Basel) | 2022 | 35158733 | PubTator, text mining | PubMed |
Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology. | Acta Neuropathol Commun | 2022 | 35144680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4739/papers?page=21